Global Drug and Alcohol Screening Market Size by Sample Type, Application, End-User, and Region – Segment-Wise Market Assessment, Growth Opportunity Analysis, Competitive Landscape Mapping & Forecast to 2030

17.2%
CAGR (2024-2030)
7.4 USD Bn.
Market Size
313
Report Pages
158
Market Tables

Overview

Drug and Alcohol Screening Market size was valued at USD 7.40 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 17.9% through 2024 to 2030, reaching nearly USD 23.57 Bn.

Drug and Alcohol Screening Market Overview:

The report explores the Drug and Alcohol Screening Market market's segments (Sample Type, Application, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2023. The report investigates the Drug and Alcohol Screening Market market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Drug and Alcohol Screening Market market's contemporary competitive scenario.Drug and Alcohol Screening MarketTo know about the Research Methodology :- Request Free Sample Report

Drug and Alcohol Screening Market Dynamics:

The primary drivers for the growth of Drugs and Alcohol Screening Market are developing medication and liquor consumption, enforcement of rigid regulations ordering medication and liquor testing and presence of government subsidizing in significant business sectors. The rising utilization of illegal medications and liquor will additionally build the advancement of medication screening items and administrations out and about, accordingly driving the market growth.

A few nations like Colombia, Argentina, Chile, and South Africa, think about drug and liquor testing at work to be a breaking of worker protection. In Poland and the Czech Republic, drug and liquor tests in the working environment are preventive. In Canada, the Eastern Canadian case regulations license drug and liquor testing just when work environment tasks are intrinsically hazardous or where medication and liquor testing is restricted to a couple of extraordinary cases.

Unique finger impression based drug testing is a moderately new idea that has acquired importance because of the COVID-19. Covid-19 has made it hard to execute drug testing in medical clinics, labs, and different offices due to the fear of transmitting disease. This test is exceptionally simple to execute at whatever point and any place required, subsequently offering adaptable and successful work environment drug testing.

Covid-19 Impact on Global Drug and Alcohol Screening Market:

About 21% of individual have detailed a downfall of 61% or more in the quantity of medication tests attempted on their representatives during the COVID-19. This is set to a few variables, remembering a decline in the quantity of individuals tried due to an expansion in the quantity of representative’s home working and general worries about working environment drug testing security and COVID-19 shields. Likewise, according to the examination article distributed in Population Health Management, 2022, a critical decrease in the testing illegal medications was noticed.

Global Drugs and Alcohol Screening Market Trends:

Factors like growth in alcohol consumption between the youth and old citizens by excessive use of prescribed drugs, and increase in use of narcotics and illegal drugs drive the global drug screening market. Rise in competition between manufacturers nourishes the growth of the market across the globe.

High-tech development is anticipated to drive the global drug screening market in the future. However, rise in awareness about propelling under the influence of drugs and banning of alcohol and drugs at workplace & government agencies are likely to slow down the market growth during the forecast period.

Drug and Alcohol Screening Market Segment Analysis:

Based on Application, the Global Drugs and Alcohol Screening Market are segmented into Workplace, Criminal Justice Systems and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, and Drug Testing Laboratories. The Workplace segment held the largest market share accounting for XX% in 2023. It is widely used in workplace to test the workers and then by which if there is drug abuse then they can suggest for check-up or to attend counselling programs and drug treatment centres helps to addicted patients to recover from drugs.

Drug and Alcohol Screening Market Regional Insights:

The North America region held the largest market share accounting for XX% in 2023. Asia Pacific has the market share of XX%, Europe has covered XX% and rest with XX%. North America is expected to overwhelm the worldwide medication screening market because of growth in the quantity of medication and liquor misuse cases and order of tough regulations in the area. Organ-on-a-chip innovations are added on to the development of North America. Organ-on-a-chip permits better and accurate insight into the possible outcome.

The objective of the report is to present a comprehensive analysis of the global Barium Fluoride Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Barium Fluoride Market dynamic, and structure by analysing the market segments and projecting the Barium Fluoride Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Barium Fluoride Market make the report investor’s guide.

Drug and Alcohol Screening Industry EcosystemDrug and Alcohol Screening Industry Ecosystem

Drug and Alcohol Screening Market Scope: Inquiry Before Buying

Drug and Alcohol Screening Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: USD 7.40 Bn.
Forecast Period 2024 to 2030 CAGR: 17.2% Market Size in 2030: USD 23.57 Bn.
Segments Covered: by Sample Type Urine samples
Oral fluid samples
Hair samples
Others
by Application Workplace
Criminal Justice Systems and Law Enforcement Agencies
Drug Treatment Centers
Pain Management Centers
Drug Testing Laboratories

Drug and Alcohol Screening Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Drug and Alcohol Screening Market Key Players:

1. Abbott Laboratories (Abbott Park, Illinois, USA)
2. Quest Diagnostics (Secaucus, New Jersey, USA)
3. LabCorp (Laboratory Corporation of America Holdings) (Burlington, North Carolina, USA)
4. Alere Inc. (Waltham, Massachusetts, USA)
5. Siemens Healthineers (Erlangen, Germany)
6. Thermo Fisher Scientific (Waltham, Massachusetts, USA)
7. OraSure Technologies, Inc. (Bethlehem, Pennsylvania, USA)
8. Bio-Rad Laboratories (Hercules, California, USA)
9. Drägerwerk AG & Co. KGaA (Lübeck, Germany)
10. F. Hoffmann-La Roche AG (Basel, Switzerland)
11. Psychemedics Corporation (Acton, Massachusetts, USA)
12. Omega Laboratories, Inc. (Mogadore, Ohio, USA)
13. Randox Laboratories (Crumlin, Northern Ireland, UK)
14. Lifeloc Technologies, Inc. (Wheat Ridge, Colorado, USA)
15. MPD, Inc. (Medtox Diagnostics) (Owensboro, Kentucky, USA)
16. Others

Frequently Asked Questions:

1] What segments are covered in the market report?
Ans. The segments covered in the market report are based on the Drug Type, and Application.

2] Which region is expected to hold the highest share in the market?
Ans. The North America region is expected to hold the highest share in the market.

3] What is the market size of the market by 20230?
Ans. The market size of the market by 2030 is expected to reach nearly US$ 23.57 Bn.

4] What is the forecast period for the market?
Ans. The forecast period for the market is 2024-2030.

5] What was the market size of the market in 2023?
Ans. The market size of the market in 2023 was valued at US$ 7.40 Bn.

Table of Contents

1. Drug and Alcohol Screening Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Drug and Alcohol Screening Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Growth Rate (Y-O-Y in %) 2.5.6. Global Presence 2.5.7. Key Development 2.5.8. Market Share 2.6. Industry Ecosystem 2.6.1. Key players in the Drug and Alcohol Screening ecosystem 2.6.2. Technology Analysis 2.6.2.1. Key Technologies 2.6.2.1.1. Sweat patch testing 2.6.2.1.2. Alcohol ignition interlock device 2.6.2.1.3. Point-of-care testing 2.6.2.2. Complementary Technology 2.6.2.2.1. Artificial Intelligence and machine learning 2.6.2.2.2. Biosensors 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Consolidation of the Market 2.8.1. Strategic Initiatives and Developments 2.8.2. Mergers and Acquisitions 2.8.3. Collaborations and Partnerships 2.8.4. Product Launches and Innovations 3. Drug and Alcohol Screening Market: Dynamics 3.1. Drug and Alcohol Screening Market Trends by Region 3.2. Drug and Alcohol Screening Market Dynamics by Region 3.2.1.1. Drivers 3.2.1.2. Restraints 3.2.1.3. Opportunities 3.2.1.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Regulatory Landscape 3.5.1. Regulation by Region, country 3.5.1.1. US 3.5.1.2. Finland 3.5.1.3. Sweden 3.5.1.4. France 3.5.1.5. Italy 3.5.1.6. UK 3.5.1.7. Netherlands 3.5.1.8. Ireland 3.5.1.9. Japan 3.5.1.10. China 3.5.1.11. India 3.5.1.12. Australia and New Zealand 3.5.2. Tariff Analysis 3.5.3. Tariff of chromatography instruments (HS CODE: 902720) 3.5.4. Analysis of Government Schemes and Initiatives on the Global Drug and Alcohol Screening Industry 3.5.5. Regulatory Bodies, Government Agencies and Other Organizations by Region 4. Drug and Alcohol Screening Market: Global Market Size and Forecast by Segmentation (by Value USD Mn) (2023-2030) 4.1. Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 4.1.1. Urine samples 4.1.2. Oral fluid samples 4.1.3. Hair samples 4.1.4. Others 4.2. Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 4.2.1. Workplace 4.2.2. Criminal Justice Systems and Law Enforcement Agencies 4.2.3. Drug Treatment Centers 4.2.4. Pain Management Centers 4.2.5. Drug Testing Laboratories 4.3. Drug and Alcohol Screening Market Size and Forecast, by Region (2023-2030) 4.3.1. North America 4.3.2. Europe 4.3.3. Asia Pacific 4.3.4. South America 4.3.5. MEA 5. North America Drug and Alcohol Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2023-2030) 5.1. North America Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 5.1.1. Urine samples 5.1.2. Oral fluid samples 5.1.3. Hair samples 5.1.4. Others 5.2. North America Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 5.2.1. Workplace 5.2.2. Criminal Justice Systems and Law Enforcement Agencies 5.2.3. Drug Treatment Centers 5.2.4. Pain Management Centers 5.2.5. Drug Testing Laboratories 5.3. North America Drug and Alcohol Screening Market Size and Forecast, by Country (2023-2030) 5.3.1. United States 5.3.1.1. United States Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 5.3.1.1.1. Urine samples 5.3.1.1.2. Oral fluid samples 5.3.1.1.3. Hair samples 5.3.1.1.4. Others 5.3.1.2. United States Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 5.3.1.2.1. Workplace 5.3.1.2.2. Criminal Justice Systems and Law Enforcement Agencies 5.3.1.2.3. Drug Treatment Centers 5.3.1.2.4. Pain Management Centers 5.3.1.2.5. Drug Testing Laboratories 5.3.2. Canada 5.3.2.1. Canada Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 5.3.2.1.1. Urine samples 5.3.2.1.2. Oral fluid samples 5.3.2.1.3. Hair samples 5.3.2.1.4. Others 5.3.2.2. Canada Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 5.3.2.2.1. Workplace 5.3.2.2.2. Criminal Justice Systems and Law Enforcement Agencies 5.3.2.2.3. Drug Treatment Centers 5.3.2.2.4. Pain Management Centers 5.3.2.2.5. Drug Testing Laboratories 5.3.3. Mexico 5.3.3.1. Mexico Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 5.3.3.1.1. Urine samples 5.3.3.1.2. Oral fluid samples 5.3.3.1.3. Hair samples 5.3.3.1.4. Others 5.3.3.2. Mexico Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 5.3.3.2.1. Workplace 5.3.3.2.2. Criminal Justice Systems and Law Enforcement Agencies 5.3.3.2.3. Drug Treatment Centers 5.3.3.2.4. Pain Management Centers 5.3.3.2.5. Drug Testing Laboratories 6. Europe Drug and Alcohol Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2023-2030) 6.1. Europe Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.2. Europe Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3. Europe Drug and Alcohol Screening Market Size and Forecast, by Country (2023-2030) 6.3.1. United Kingdom 6.3.1.1. United Kingdom Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.1.2. United Kingdom Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.2. France 6.3.2.1. France Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.2.2. France Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.3. Germany 6.3.3.1. Germany Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.3.2. Germany Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.4. Italy 6.3.4.1. Italy Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.4.2. Italy Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.5. Spain 6.3.5.1. Spain Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.5.2. Spain Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.6. Sweden 6.3.6.1. Sweden Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.6.2. Sweden Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.7. Austria 6.3.7.1. Austria Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.7.2. Austria Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 6.3.8. Rest of Europe 6.3.8.1. Rest of Europe Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 6.3.8.2. Rest of Europe Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7. Asia Pacific Drug and Alcohol Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2023-2030) 7.1. Asia Pacific Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.2. Asia Pacific Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3. Asia Pacific Drug and Alcohol Screening Market Size and Forecast, by Country (2023-2030) 7.3.1. China 7.3.1.1. China Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.1.2. China Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3.2. S Korea 7.3.2.1. S Korea Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.2.2. S Korea Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3.3. Japan 7.3.3.1. Japan Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.3.2. Japan Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3.4. India 7.3.4.1. India Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.4.2. India Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3.5. Australia 7.3.5.1. Australia Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.5.2. Australia Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3.6. ASEAN 7.3.6.1. ASEAN Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.6.2. ASEAN Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 7.3.7. Rest of Asia Pacific 7.3.7.1. Rest of Asia Pacific Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 7.3.7.2. Rest of Asia Pacific Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 8. South America Drug and Alcohol Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2023-2030) 8.1. South America Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 8.2. South America Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 8.3. South America Drug and Alcohol Screening Market Size and Forecast, by Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 8.3.1.2. Brazil Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 8.3.2.2. Argentina Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 8.3.3. Rest of South America 8.3.3.1. Rest of South America Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 8.3.3.2. Rest of South America Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 9. Middle East and Africa Drug and Alcohol Screening Market Size and Forecast by Segmentation (by Value USD Mn) (2023-2030) 9.1. Middle East and Africa Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 9.2. Middle East and Africa Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 9.3. Middle East and Africa Drug and Alcohol Screening Market Size and Forecast, by Country (2023-2030) 9.3.1. South Africa 9.3.1.1. South Africa Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 9.3.1.2. South Africa Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 9.3.2. GCC 9.3.2.1. GCC Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 9.3.2.2. GCC Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 9.3.3. Rest of MEA 9.3.3.1. Rest of MEA Drug and Alcohol Screening Market Size and Forecast, by Sample Type (2023-2030) 9.3.3.2. Rest of MEA Drug and Alcohol Screening Market Size and Forecast, by Application (2023-2030) 10. Company Profile: Key Players 10.1. Abbott Laboratories (Abbott Park, Illinois, USA) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis (Technological strengths and weaknesses) 10.1.5. Strategic Analysis (Recent strategic moves) 10.1.6. Recent Developments 10.2. Quest Diagnostics (Secaucus, New Jersey, USA) 10.3. LabCorp (Laboratory Corporation of America Holdings) (Carolina, USA) 10.4. Alere Inc. (Waltham, Massachusetts, USA) 10.5. Siemens Healthineers (Erlangen, Germany) 10.6. Thermo Fisher Scientific (Waltham, Massachusetts, USA) 10.7. OraSure Technologies, Inc. (Bethlehem, Pennsylvania, USA) 10.8. Bio-Rad Laboratories (Hercules, California, USA) 10.9. Drägerwerk AG & Co. KGaA (Lübeck, Germany) 10.10. F. Hoffmann-La Roche AG (Basel, Switzerland) 10.11. Psychemedics Corporation (Acton, Massachusetts, USA) 10.12. Omega Laboratories, Inc. (Mogadore, Ohio, USA) 10.13. Randox Laboratories (Crumlin, Northern Ireland, UK) 10.14. Lifeloc Technologies, Inc. (Wheat Ridge, Colorado, USA) 10.15. MPD, Inc. (Medtox Diagnostics) (Owensboro 10.16. Others 11. Key Findings and Analyst Recommendations 11.1. Attractive Opportunities for Players in the Drug and Alcohol Screening Market 12. Drug and Alcohol Screening Market: Research Methodology 13. Market Size Estimation Methodology 13.1. Research Data 13.1.1. Secondary Data 13.1.1.1. Key data from Secondary Sources 13.1.2. Primary Data 13.1.2.1. Key data from primary Sources 13.1.2.2. Breakdown of primaries 13.1.3. Bottom-Up Approach 13.1.4. Top-Down Approach 13.1.5. Forecast 13.1.6. Data Triangulation 13.1.7. Research Assumptions 13.1.8. Limitations and Risk Assessment